Skip to Sidebar Skip to Content

SoftBank Vision Fund 2

SoftBank's London-managed growth fund; led rounds for CMR Surgical, Gousto and OakNorth

  • Venture capital
  • London
Type
Venture capital
Based in
London
Stages
Growth, Series B+
Sector focus
AI & Data, Hardware & Robotics, SaaS & B2B, Fintech, Healthtech, Consumer
Cheque size
Large growth cheques, typically $100M+ (e.g. $390M into OakN
Fund size
$30B (Vision Fund 2, upsized 2021)
Founded
2019

SoftBank Vision Fund 2 is the second of SoftBank Group's technology growth funds, managed by SB Investment Advisers (UK) Limited from London's Mayfair. Launched in 2019 and later upsized to around $30 billion, it is funded by SoftBank itself and invests large growth cheques in companies it sees as driving the transition to an AI economy, spanning semiconductors and compute, data infrastructure and consumer and enterprise applications. In the UK, SoftBank's Vision Funds have led CMR Surgical's Series D in 2021, Gousto's 2022 growth round and OakNorth's $390 million round in 2019, typically as the lead investor at late stage.

Team

  • Alex Clavel, CEO, SoftBank Investment Advisers
  • Greg Moon, Executive Managing Partner
  • Mark Agne, Executive Managing Partner
  • Sumer Juneja, Managing Partner, Head of EMEA & India Investing

Portfolio in the directory

Add this profile to your website

Show this card on your own site. It reads “As seen on EP+” and links back to this page.

Paste it anywhere your site accepts HTML. Is this your organisation? Request an update if the card is out of date.

← All investors · Is this your organisation? Request an update

More investors in the directory

Subscribe to Newsletter

UK startup news, founder stories and funding insight, straight to your inbox every week. Free.